Objective: To investigate the relative efficacy of four popular weight-loss programmes on plasma lipids and lipoproteins as measures of CVD risk. Design: A multi-centred, randomised, controlled trial of four diets -Dr Atkins' New Diet Revolution, The Slim-Fast Plan, Weight Watchers Pure Points programme and Rosemary Conley's 'Eat yourself Slim' Diet and Fitness Plan -against a control diet, in parallel for 6 months. Setting and subjects: The trial was conducted at five universities across the UK (Surrey, Nottingham, Ulster (Coleraine), Bristol and Edinburgh (Queen Margaret University College)) and involved the participation of 300 overweight and obese males and females aged 21-60 years in a community setting. Results: Significant weight loss was achieved by all dieting groups (5-9 kg at 6 months) but no significant difference was observed between diets at 6 months. The Weight Watchers and Rosemary Conley (low-fat) diets were followed by significant reductions in plasma LDL cholesterol (both 212?2 % after 6 months, P , 0?01), whereas the Atkins (low-carbohydrate) and Weight Watchers diets were followed by marked reductions in plasma TAG (-38?2 % and -22?6 % at 6 months respectively, P , 0?01). These latter two diets were associated with an increase in LDL particle size, a change that has been linked to reduced CVD risk. Conclusions: Overall, these results demonstrate the favourable effects of weight loss on lipid-mediated CVD risk factors that can be achieved through commercially available weight-loss programmes. No detrimental effects on lipid-based CVD risk factors were observed in participants consuming a low-carbohydrate diet.
KeywordsLipids Lipoprotein sub-fractions Weight-loss programmes Cardiovascular diseaseThe prevalence of obesity in the UK is increasing, with 41 % of adult men and 33 % of women being overweight and an additional 25 % and 20 % respectively being obese (1) . As the health, economic and social costs of obesity have become increasingly apparent, the number and variety of weight-loss programmes has multiplied. Numerous dieting programmes are currently available that focus on different strategies for reducing energy intake, by restricting specific macronutrients (fat or carbohydrate), controlling portion size or replacing meals with substitutes.Obesity is one of the major modifiable risk factors for CVD. Weight loss per se results in favourable changes in blood lipid profiles, decreasing circulating LDL cholesterol (LDL-C) and TAG levels and increasing HDL cholesterol (HDL-C) if weight loss is maintained (2) .However, restriction of specific macronutrients can produce differential effects on lipid profiles. High-carbohydrate, low-fat diets, while decreasing LDL-C, have a tendency to increase plasma TAG concentrations and decrease HDL-C (3) , whereas low-carbohydrate diets, though effective in lowering plasma TAG concentrations, can be inherently high in saturated fat and cholesterol and show variable effects on LDL-C (4)(5)(6)(7)(8) . Obesity is frequently associated with raised plas...